SABS

NASDAQ · Equity

SAB Biotherapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
3.600000
Fair value
4.141021
Expectation
Negative 44.40%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.60
12-Week Change
-13.25%
Trend Signal
Inactive
Expectation
Negative 44.40%
Signal Weeks
8 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-6.06
Market Dynamics
-0.52

Over the latest 12 completed weeks ending 2026-05-29, SABS fell 13.25%, moving from 4.15 to 3.60. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 8 of the last 12 weeks. Relative Strength is -6.06 and has softened across the 12-week window. Market Dynamics is -0.52 on the latest week. Expectation is negative at 44.40%.